Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Afimoxifene + XMU-MP-2 |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Afimoxifene | 4-Hydroxy-Tamoxifen|4-hydroxytamoxifen|Hydroxytamoxifen | Hormone - Anti-estrogens 29 | Afimoxifene (4-hydroxy-tamoxifen) is a metabolite of tamoxifen, which binds to the estrogen receptor and acts as an antagonist in tumor cells (PMID: 32019136). | |
XMU-MP-2 | XMU-MP-2 is a small molecule that inhibits PTK6 (BRK), resulting in decreased downstream signaling and reduced proliferation of PTK6 (BRK)-expressing tumor cells (PMID: 27758886). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|